BRIEF—Cadila acquires 51% stake in Windlas Healthcare

In a strategic move, Cadila Healthcare, an Indian healthcare provider, announced that it will be acquiring 51% stake in Dehradun-based Windlas Healthcare, with not financial terms of the deal provided.

Speaking on the development, managing director of Cadila Healthcare, Dr Sharvil Patel, said: “We see this as an opportunity to ramp up our operations and increase our product offerings. Windlas Healthcare’s cost-efficient manufacturing infrastructure and technical competence to develop a competitive product pipeline will be a great asset for us.”

Windlas Healthcare has a robust manufacturing infrastructure with a US Food and Drug Administration-inspected oral solids manufacturing facility.

Windlas also has a dedicated R&D facility for formulations development and has developed four first-to-file Abbreviated New Drug Applications (ANDAs) in the last two years.

The strategic deal allows Cadila Healthcare to expand its existing manufacturing base.